The trajectory of the erectile dysfunction drug presents a challenging picture for shareholders. While the initial release generated substantial profits, the lapse of its patent opened the avenue to cheaper https://ilovebookmarking.com/story21637961/sildenafil-and-the-pharmaceutical-industry-a-precarious-bet